$60.34
+1.4%The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Executive Vice President & Chief Operating Officer
Compensation
$943,666
Executive Vice President, Chief Financial Officer & Treasurer
Compensation
$738,563
General Counsel & Secretary
President of CooperSurgical, Inc.
Compensation
$692,730
President of CooperVision, Inc.
Compensation
$653,733
President, Chief Executive Officer & Non-Independent Director
Compensation
$1,245,567
Senior Vice President & Chief Accounting Officer
Compensation
$670,709
Vice President of Investor Relations & Risk Management
Vice President, General Counsel & Corporate Secretary
During the last 12 months, insiders have purchased $2.52M worth of COO shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
16.0K
1.30M
0
0.00
+1.3M
+$1.30M
2.0K
136.78K
0
0.00
+137K
+$137K
16.0K
1.08M
0
0.00
+1.1M
+$1.08M
White Albert G Iii
Director, Officer: President & Ceo
$1.49M
Kurzius Lawrence Erik
Director
$302K
Mcbride Daniel G
Officer: Evp & Chief Operating Officer
$195K
Lucchese Cynthia L
Director
$150K
Warner Gerard H Iii
Officer: President, Coopervision, Inc.
$100K
No selling activity
Strong bullish signal with $2.52M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero sellingโthe most bullish possible insider signal.
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
COO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | February 24, 2026 | April 07, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | February 19, 2025 | April 02, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | February 02, 2024 | March 19, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | January 30, 2023 | March 15, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | January 28, 2022 | March 16, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | January 29, 2021 | March 17, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | February 04, 2020 | March 18, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | February 01, 2019 | March 18, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | February 02, 2018 | March 19, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | January 27, 2017 | March 13, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.